1407 GMT - Reckitt Benckiser investors are likely to focus on 2025 outlook as nothing major happened since the last earnings, Barclays analysts say in a note. The U.K. consumer-goods company is expected to provide 2025 guidance of 3% to 5% organic sales growth for its core business, which excludes essential home and Mead Johnson, they say. However, Reckitt could also issue a conservative target given the limited visibility, and volatility due to flu and retailer inventory dynamics, the analysts add. They warn, however, that almost every global health and personal care products company warned of an unusually weak 1Q, meaning the health segment could face pressures. Reckitt reports its 2024 results on Thursday. Shares are up 0.3% at 52.54 pounds. (michael.susin@wsj.com)
(END) Dow Jones Newswires
March 03, 2025 09:08 ET (14:08 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。